VisionWave inks $30 million at-the-market equity sales agreement with Aegis Capital
VWAV•Fees and use of proceeds
Aegis will earn a 2% commission on gross proceeds; the company also agreed to reimburse certain expenses up to USD 37,500.
Net proceeds, if any, are earmarked for general corporate purposes and working capital.
At-the-market equity sales agreement
VisionWave Holdings entered an at-the-market issuance sales agreement with Aegis Capital to sell up to USD 30 million of common stock.
Shares may be sold from time to time on Nasdaq or other trading venues, subject to company instructions on size or price limits.
